Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms

Dr Akhil Kapoor - Tata Memorial Center, Mumbai, India
Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms ( Dr Akhil Kapoor - Tata Memorial Center, Mumbai, India )
15 May 2020

A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer

Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA
A first-of-its-kind prospective study of a multi-cancer blood test to screen and manage 10,000 women with no history of cancer ( Prof Nickolas Papadopoulos - Johns Hopkins Medicine, Baltimore, USA )
13 May 2020

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic

Dr Heather Wakelee - Stanford University, Stanford, USA
COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )
12 May 2020

Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic?

Dr Raghavan Vidya - The Royal Wolverhampton NHS Trust, Wolverhampton, UK
Should breast reconstruction and breast oncoplastic procedures be performed during the coronavirus pandemic? ( Dr Raghavan Vidya - The Royal Wolverhampton NHS Trust, Wolverhampton, UK )
12 May 2020

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19

Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland
Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )
7 May 2020

Managing toxicities associated with immune-checkpoint inhibitors

Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France
Managing toxicities associated with immune-checkpoint inhibitors ( Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France )
6 May 2020

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer

Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA
I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )
5 May 2020

COVID-19: Managing paediatric patients under the COVID pandemic

Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami
COVID-19: Managing paediatric patients under the COVID pandemic ( Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami )
4 May 2020

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia
IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )
1 May 2020

An oncologist's experience of managing breast cancer during the COVID-19 outbreak

Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy
An oncologist's experience of managing breast cancer during the COVID-19 outbreak ( Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy )
28 Apr 2020

COVID-19: The situation in Florida and managing lung cancer patients

Dr. Luis Raez - Memorial Healthcare System, Florida, Miami
COVID-19: The situation in Florida and managing lung cancer patients ( Dr. Luis Raez - Memorial Healthcare System, Florida, Miami )
27 Apr 2020

New oncogenic drivers in NSCLC

Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands
New oncogenic drivers in NSCLC ( Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands )
23 Apr 2020